24 results on '"Jo Bowen"'
Search Results
2. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
- Author
-
Gerhardt Attard, Laura Murphy, Noel W Clarke, William Cross, Robert J Jones, Christopher C Parker, Silke Gillessen, Adrian Cook, Chris Brawley, Claire L Amos, Nafisah Atako, Cheryl Pugh, Michelle Buckner, Simon Chowdhury, Zafar Malik, J Martin Russell, Clare Gilson, Hannah Rush, Jo Bowen, Anna Lydon, Ian Pedley, Joe M O'Sullivan, Alison Birtle, Joanna Gale, Narayanan Srihari, Carys Thomas, Jacob Tanguay, John Wagstaff, Prantik Das, Emma Gray, Mymoona Alzoueb, Omi Parikh, Angus Robinson, Isabel Syndikus, James Wylie, Anjali Zarkar, George Thalmann, Johann S de Bono, David P Dearnaley, Malcolm D Mason, Duncan Gilbert, Ruth E Langley, Robin Millman, David Matheson, Matthew R Sydes, Louise C Brown, Mahesh K B Parmar, Nicholas D James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, Dakshinamoorthy Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, Mohammed Kagzi, Carmel Pezaro, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan McLaren, Nishi Gupta, Stergios Boussios, Henry Taylor, John Graham, Carla Perna, Lucinda Melcher, Warren Grant, Ami Sabharwal, Uschi Hofmann, Robert Dealey, Neil McPhail, Robert Brierly, Lisa Capaldi, Norma Sidek, Peter Whelan, Peter Robson, Alison Falconer, Sarah Rudman, Sindu Vivekanandan, Vinod Mullessey, Maria Vilarino-Varela, Vincent Khoo, Karen Tipples, Mehran Afshar, Patryk Brulinski, Vijay Sangar, Clive Peedell, Ashraf Azzabi, Peter Hoskin, Viwod Mullassery, Santhanam Sundar, Yakhub Khan, Ruth Conroy, Andrew Protheroe, Judith Carser, Paul Rogers, Kathryn Tarver, Stephanie Gibbs, Mohammad Muneeb Khan, Mohan Hingorani, Simon Crabb, Manal Alameddine, Neeraj Bhalla, Robert Hughes, John Logue, Darren Leaning, Salil Vengalil, Daniel Ford, Georgina Walker, Ahmed Shaheen, Omar Khan, Andrew Chan, Imtiaz Ahmed, Serena Hilman, Ian Sayers, Ashok Nikapota, David Bloomfield, Tim Porter, Joji Joseph, Cyrill Rentsch, Ricardo Pereira Mestre, Enrico Roggero, Jörg Beyer, Markus Borner, Raeto Strebel, Dominik Berthold, Daniel Engeler, Hubert John, Razvan Popescu, and Donat Durr
- Subjects
Male ,Prostatectomy ,Prednisolone ,Abiraterone Acetate ,Prostatic Neoplasms ,610 Medicine & health ,General Medicine ,Disease-Free Survival ,Progression-Free Survival ,SDG 3 - Good Health and Well-being ,Clinical Trials, Phase III as Topic ,Chemotherapy, Adjuvant ,Antineoplastic Combined Chemotherapy Protocols ,Benzamides ,Nitriles ,Phenylthiohydantoin ,Humans ,Multicenter Studies as Topic ,Neoplasm Grading ,Neoplasm Recurrence, Local ,Randomized Controlled Trials as Topic - Abstract
BACKGROUND Men with high-risk non-metastatic prostate cancer are treated with androgen-deprivation therapy (ADT) for 3 years, often combined with radiotherapy. We analysed new data from two randomised controlled phase 3 trials done in a multiarm, multistage platform protocol to assess the efficacy of adding abiraterone and prednisolone alone or with enzalutamide to ADT in this patient population. METHODS These open-label, phase 3 trials were done at 113 sites in the UK and Switzerland. Eligible patients (no age restrictions) had high-risk (defined as node positive or, if node negative, having at least two of the following: tumour stage T3 or T4, Gleason sum score of 8-10, and prostate-specific antigen [PSA] concentration ���40 ng/mL) or relapsing with high-risk features (���12 months of total ADT with an interval of ���12 months without treatment and PSA concentration ���4 ng/mL with a doubling time of
- Published
- 2021
- Full Text
- View/download PDF
3. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
- Author
-
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, Abdulla Alhasso, David J Bloomfield, Charlie Chan, Mark Churn, Susan Cleator, Charlotte E Coles, Andrew Goodman, Adrian Harnett, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Carolyn Morris, Zohal Nabi, Elinor Sawyer, Navita Somaiah, Liba Stones, Isabel Syndikus, Judith M Bliss, John R Yarnold, Anne Armstrong, Judith Bliss, David Bloomfield, Jo Bowen, Murray Brunt, Hannah Chantler, Charlotte Coles, Ellen Donovan, Andy Goodman, Susan Griffin, Jo Haviland, Penny Hopwood, Anna Kirby, Julie Kirk, Cliona Kirwan, Marjory MacLennan, Mark Sculphur, Judith Sinclair, Mark Sydenham, Jean Tremlett, Karen Venables, Duncan Wheatley, John Yarnold, and Apollo - University of Cambridge Repository
- Subjects
medicine.medical_treatment ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,law.invention ,0302 clinical medicine ,Randomized controlled trial ,law ,Radiotherapy, Adjuvant/adverse effects ,Clinical endpoint ,030212 general & internal medicine ,Neoplasm Metastasis ,Mastectomy ,Neoplasm Recurrence, Local/epidemiology ,Aged, 80 and over ,Manchester Cancer Research Centre ,United Kingdom/epidemiology ,Hazard ratio ,General Medicine ,Middle Aged ,Treatment Outcome ,Female ,Radiation Dose Hypofractionation ,Adult ,Breast Neoplasms/mortality ,Breast Neoplasms ,Risk Assessment ,Article ,03 medical and health sciences ,Breast cancer ,medicine ,Humans ,Risk Assessment/methods ,Radiation Injuries ,Aged ,Neoplasm Staging ,business.industry ,ResearchInstitutes_Networks_Beacons/mcrc ,medicine.disease ,R1 ,United Kingdom ,Mastectomy/methods ,Radiation therapy ,Clinical trial ,Regimen ,Radiation Injuries/epidemiology ,Radiotherapy, Adjuvant ,Neoplasm Grading ,Neoplasm Recurrence, Local ,business ,Nuclear medicine ,RA ,Follow-Up Studies - Abstract
BACKGROUND: We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after primary surgery for early breast cancer. Here, we present 5-year results of the FAST-Forward trial.METHODS: FAST-Forward is a multicentre, phase 3, randomised, non-inferiority trial done at 97 hospitals (47 radiotherapy centres and 50 referring hospitals) in the UK. Patients aged at least 18 years with invasive carcinoma of the breast (pT1-3, pN0-1, M0) after breast conservation surgery or mastectomy were eligible. We randomly allocated patients to either 40 Gy in 15 fractions (over 3 weeks), 27 Gy in five fractions (over 1 week), or 26 Gy in five fractions (over 1 week) to the whole breast or chest wall. Allocation was not masked because of the nature of the intervention. The primary endpoint was ipsilateral breast tumour relapse; assuming a 2% 5-year incidence for 40 Gy, non-inferiority was predefined as ≤1·6% excess for five-fraction schedules (critical hazard ratio [HR] of 1·81). Normal tissue effects were assessed by clinicians, patients, and from photographs. This trial is registered at isrctn.com, ISRCTN19906132.FINDINGS: Between Nov 24, 2011, and June 19, 2014, we recruited and obtained consent from 4096 patients from 97 UK centres, of whom 1361 were assigned to the 40 Gy schedule, 1367 to the 27 Gy schedule, and 1368 to the 26 Gy schedule. At a median follow-up of 71·5 months (IQR 71·3 to 71·7), the primary endpoint event occurred in 79 patients (31 in the 40 Gy group, 27 in the 27 Gy group, and 21 in the 26 Gy group); HRs versus 40 Gy in 15 fractions were 0·86 (95% CI 0·51 to 1·44) for 27 Gy in five fractions and 0·67 (0·38 to 1·16) for 26 Gy in five fractions. 5-year incidence of ipsilateral breast tumour relapse after 40 Gy was 2·1% (1·4 to 3·1); estimated absolute differences versus 40 Gy in 15 fractions were -0·3% (-1·0 to 0·9) for 27 Gy in five fractions (probability of incorrectly accepting an inferior five-fraction schedule: p=0·0022 vs 40 Gy in 15 fractions) and -0·7% (-1·3 to 0·3) for 26 Gy in five fractions (p=0·00019 vs 40 Gy in 15 fractions). At 5 years, any moderate or marked clinician-assessed normal tissue effects in the breast or chest wall was reported for 98 of 986 (9·9%) 40 Gy patients, 155 (15·4%) of 1005 27 Gy patients, and 121 of 1020 (11·9%) 26 Gy patients. Across all clinician assessments from 1-5 years, odds ratios versus 40 Gy in 15 fractions were 1·55 (95% CI 1·32 to 1·83, pINTERPRETATION: 26 Gy in five fractions over 1 week is non-inferior to the standard of 40 Gy in 15 fractions over 3 weeks for local tumour control, and is as safe in terms of normal tissue effects up to 5 years for patients prescribed adjuvant local radiotherapy after primary surgery for early-stage breast cancer.FUNDING: National Institute for Health Research Health Technology Assessment Programme.
- Published
- 2020
- Full Text
- View/download PDF
4. Managing Asbestos-Containing Materials in the Built Environment: Report of a Health and Safety Executive and Government Office for Science Workshop
- Author
-
Laurie S. T. Davies, Garry John Burdett, Jo Bowen, and Christopher Michael Barber
- Subjects
Risk ,0301 basic medicine ,Engineering ,Public interest ,03 medical and health sciences ,0302 clinical medicine ,Occupational Exposure ,Humans ,Health policy ,Built environment ,Government ,Construction Materials ,business.industry ,Health Policy ,Public Health, Environmental and Occupational Health ,Stakeholder ,Asbestos ,Environmental Exposure ,Environmental exposure ,Public relations ,Service provider ,United Kingdom ,Engineering management ,030104 developmental biology ,Facility Design and Construction ,030220 oncology & carcinogenesis ,Government Regulation ,Government Office ,business ,Environmental Monitoring - Abstract
The duty to manage asbestos in non-domestic premises is described in the Control of Asbestos Regulations 2012. Health and Safety Executive (HSE) policy and guidance on asbestos in the built environment in Great Britain is that asbestos-containing materials (ACMs) that are in good condition and unlikely to be disturbed can be managed in place. Where ACMs are in poor condition or likely to be disturbed they should be repaired, encapsulated or, if necessary, removed. HSE and Government Office for Science hosted a stakeholder workshop to consider evidence on the management of ACMs in public buildings. Invitees attended from a range of backgrounds (including regulatory, government, academic, medical, public interest groups, and professional service providers). Participants considered the evidence, suggested nine evidence gap areas and ranked these according to preference in an anonymous vote. The top three suggested evidence gaps were: (i) the comparative risks of managing ACMs in place versus removal; (ii) improved measurement techniques at lower fibre concentrations; and (iii) building the evidence base on the effectiveness of asbestos management and safe removal. HSE will use the workshop outputs to inform its research planning. It is anticipated that a number of initiatives for shared research will be explored.
- Published
- 2017
- Full Text
- View/download PDF
5. Physical activity and self-esteem: ‘Jonny’s story’
- Author
-
Kristy Howells and Jo Bowen
- Subjects
media_common.quotation_subject ,education ,05 social sciences ,Physical activity ,Self-esteem ,050301 education ,030229 sport sciences ,Academic achievement ,Education ,03 medical and health sciences ,Interpersonal relationship ,0302 clinical medicine ,Scale (social sciences) ,Intervention (counseling) ,Well-being ,Confidentiality ,Life-span and Life-course Studies ,Psychology ,0503 education ,Social psychology ,media_common - Abstract
Previous research has proposed that physical exercise can raise selfesteem. This paper will examine the extent to which physical activity interventions, within one case study primary school supported the development of self-esteem of a (junior) year 5 child over a period of five months. Jonny was 10 years old when the physical activity intervention commenced. His name is a pseudonym to protect his confidentiality. Jonny had been measured on the school's wellbeing measurement scale and was reported to have a very low self-esteem, which had affected his learning through the previous two years in primary school. He was working in the low ability sets for both Mathematics and English and his self-esteem had hindered his ability to make and develop relationships with both adults and peers within his year group. Through participating in the physical activity interventions, Jonny increased the distance that he was able to throw a shot put and hammer, he was able to describe positively his own body movements and he improved his academic performances. The findings suggest that it is possible within a primary school case study setting, to improve selfesteem through physical activity interventions.
- Published
- 2016
- Full Text
- View/download PDF
6. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- Author
-
Joanna Gale, C.L. Ferguson, J. Martin Russell, Prabir Chakraborti, Carys Thomas, Mohan Hingorani, Joe M. O'Sullivan, Anjali Zarkar, Clare Gilson, Zafar Malik, John Wagstaff, Jo Bowen, Fiona McKinna, Angus Robinson, Claire Amos, Simon Chowdhury, Alison Birtle, Fawzi Adab, Peter Hoskin, San Aung, Robin Millman, Chris Parker, Neil McPhail, Alastair W. S. Ritchie, Robert Jones, Jason F. Lester, Noel W. Clarke, Susannah Brock, Gerhardt Attard, Andrew Protheroe, James D. Wylie, Omi Parikh, Johann S. de Bono, Nicholas D. James, Julian Money-Kyrle, Malcolm David Mason, William Cross, Emma Gray, David Matheson, Dominik Berthold, Silke Gillessen, Melissa R. Spears, David P. Dearnaley, Narayanan Srihari, Matthew R. Sydes, Mahesh K.B. Parmar, Chris Brawley, and STAMPEDE Investigators
- Subjects
Oncology ,Adult ,Male ,Prednisolone/administration & dosage ,medicine.medical_specialty ,Combination therapy ,medicine.medical_treatment ,Abiraterone Acetate/administration & dosage ,Abiraterone Acetate/adverse effects ,Aged ,Aged, 80 and over ,Androgen Antagonists/administration & dosage ,Androgen Antagonists/adverse effects ,Antineoplastic Combined Chemotherapy Protocols/adverse effects ,Antineoplastic Combined Chemotherapy Protocols/therapeutic use ,Humans ,Middle Aged ,Neoplasm Metastasis/drug therapy ,Neoplasm Recurrence, Local/drug therapy ,Prednisolone/adverse effects ,Prostate-Specific Antigen/blood ,Prostatic Neoplasms/drug therapy ,Prostatic Neoplasms/mortality ,Prostatic Neoplasms/radiotherapy ,Prostatic Neoplasms/surgery ,Steroid 17-alpha-Hydroxylase/antagonists & inhibitors ,Survival Analysis ,030232 urology & nephrology ,Androgen deprivation therapy ,03 medical and health sciences ,Prostate cancer ,chemistry.chemical_compound ,0302 clinical medicine ,SDG 3 - Good Health and Well-being ,Internal medicine ,Medicine ,Gynecology ,Manchester Cancer Research Centre ,business.industry ,ResearchInstitutes_Networks_Beacons/mcrc ,Apalutamide ,Abiraterone acetate ,General Medicine ,medicine.disease ,Radiation therapy ,Prostate-specific antigen ,chemistry ,030220 oncology & carcinogenesis ,Hormone therapy ,business - Abstract
BACKGROUND: Abiraterone acetate plus prednisolone improves survival in men with relapsed prostate cancer. We assessed the effect of this combination in men starting long-term androgen-deprivation therapy (ADT), using a multigroup, multistage trial design.METHODS: We randomly assigned patients in a 1:1 ratio to receive ADT alone or ADT plus abiraterone acetate (1000 mg daily) and prednisolone (5 mg daily) (combination therapy). Local radiotherapy was mandated for patients with node-negative, nonmetastatic disease and encouraged for those with positive nodes. For patients with nonmetastatic disease with no radiotherapy planned and for patients with metastatic disease, treatment continued until radiologic, clinical, or prostate-specific antigen (PSA) progression; otherwise, treatment was to continue for 2 years or until any type of progression, whichever came first. The primary outcome measure was overall survival. The intermediate primary outcome was failure-free survival (treatment failure was defined as radiologic, clinical, or PSA progression or death from prostate cancer).RESULTS: A total of 1917 patients underwent randomization from November 2011 through January 2014. The median age was 67 years, and the median PSA level was 53 ng per milliliter. A total of 52% of the patients had metastatic disease, 20% had node-positive or node-indeterminate nonmetastatic disease, and 28% had node-negative, nonmetastatic disease; 95% had newly diagnosed disease. The median follow-up was 40 months. There were 184 deaths in the combination group as compared with 262 in the ADT-alone group (hazard ratio, 0.63; 95% confidence interval [CI], 0.52 to 0.76; PCONCLUSIONS: Among men with locally advanced or metastatic prostate cancer, ADT plus abiraterone and prednisolone was associated with significantly higher rates of overall and failure-free survival than ADT alone. (Funded by Cancer Research U.K. and others; STAMPEDE ClinicalTrials.gov number, NCT00268476 , and Current Controlled Trials number, ISRCTN78818544 .).
- Published
- 2017
- Full Text
- View/download PDF
7. 'The Bug Investigators'
- Author
-
David Gelb, Jo Bowen, Andre Charlett, and Cliodna A. M. McNulty
- Subjects
Medical education ,business.industry ,media_common.quotation_subject ,Teaching method ,education ,Public Health, Environmental and Occupational Health ,Attendance ,National curriculum ,Focus group ,Education ,Health promotion ,Nursing ,Hygiene ,Medicine ,Health education ,General knowledge ,business ,media_common - Abstract
Purpose – The aim of this study is to measure the effectiveness of the “Bug Investigators” pack in improving children's knowledge about micro‐organisms, hygiene and antibiotics when it is used within the National Curriculum in junior schools.Design/methodology/approach – Teaching, using the “Bug Investigators” pack, was given by Gloucestershire primary school teachers. Children's general knowledge about hygiene, micro‐organisms and antibiotics was measured by questionnaire before and after lessons using the pack. A sample of 198 children aged 10 and 11 years in eight primary schools completed the questionnaires before and after teaching. A focus group was held with teachers to explore their views after using the pack.Findings – Children's knowledge improved in all topic areas. Improved knowledge was most significant for what antibiotics do and how to use them and the value of our own good bugs (27, 31 and 16 percent improvement respectively). Knowledge about how bugs spread and hand hygiene was excellent ...
- Published
- 2007
- Full Text
- View/download PDF
8. Is there an opportunity to reduce urinary catheter-related infections? Exploring variation in catheterisation rates in care homes
- Author
-
Jo Bowen, A. Brady, K. Gunn, Gillian Smith, T. Ejidokun, D. S. Tompkins, Cliodna A. M. McNulty, Elaine Freeman, Chris Foy, and Ian P. Donald
- Subjects
0301 basic medicine ,Advanced and Specialized Nursing ,medicine.medical_specialty ,Physical disability ,business.industry ,Care homes ,Urinary retention ,030106 microbiology ,Staffing ,Questionnaire ,030501 epidemiology ,medicine.disease ,03 medical and health sciences ,Nursing care ,Nursing ,Emergency medicine ,Toileting ,Medicine ,Dementia ,medicine.symptom ,0305 other medical science ,business - Abstract
rinary catheterisation in care homes is associated with increased morbidity, hospitalisation and mortality. The authors aimed to determine whether staffing, resident underlying illness or nursing band, or use of other toileting methods were responsible for the wide variation in urinary catheterisation rates found in English care homes. The authors approached randomly-selected registered care homes in three former health districts in England. A questionnaire survey was used to determine the number of residents in each nursing care band and with different medical conditions that were catheterised, and the home's management of residents' continence. The number of residents or staffing did not influence catheterisation rate. Higher catheterisation rate homes had a lower proportion of high band nursing residents and residents with incontinence, severe physical disability and dementia than the other homes. Only urinary retention (3 per cent of residents) was significantly more common in the higher catheterisation rate homes. There was no difference in continence care before inserting a catheter. The authors suggest that care culture and staff attitudes to catheterisation should be explored in greater depth using structured interviews or focus groups. This may allow the identification of key factors that can be targeted in order to reduce catheterisation rates and the associated morbidity.
- Published
- 2006
- Full Text
- View/download PDF
9. Health and safety inspection of hairdressing and nail salons by local authority environmental health practitioners
- Author
-
Joanne, Harris-Roberts, Jo, Bowen, Jade, Sumner, and David, Fishwick
- Subjects
Health Knowledge, Attitudes, Practice ,Risk Management ,Inservice Training ,Nails ,Occupational Exposure ,Humans ,Guideline Adherence ,Beauty Culture ,Facility Regulation and Control ,Hazardous Substances ,United Kingdom ,Checklist - Abstract
The objective of the study described in this article was to provide environmental health practitioners (EHPs) with an evaluation of the levels of understanding of, and compliance with, health and safety legislation in hairdressing and nail salons. EHPs carried out a series of inspections of 205 salons in a large British city, consisting of a site assessment and an assessment of employee knowledge of relevant regulations, including those relating to control of exposure to hazardous substances. Two-fifths of senior salon employees understood Control of Substances Hazardous to Health (COSHH) assessments and could provide evidence of their completion. Most employees had been trained and made aware of the health hazards associated with carrying out their work and took suitable precautions to protect themselves and their clients. The results suggest that senior employees within the salons sampled, have knowledge of the risks to health and have been taking measures to control these risks. Initiatives such as the Health and Safety Executive's (in collaboration with local authorities and the hairdressing industry) "Bad Hand Day?" campaign and sector-specific COSHH essentials guidance help raise awareness levels and aim to support good control practice in salons.
- Published
- 2013
10. The Triggering Hypothesis of the Role of Life Events in Schizophrenia
- Author
-
Steven R. Hirsch, Jo Bowen, and Philip Cramer
- Subjects
Psychiatric Status Rating Scales ,medicine.medical_specialty ,Schizophrenia (object-oriented programming) ,Life events ,030227 psychiatry ,Life Change Events ,03 medical and health sciences ,Psychiatry and Mental health ,0302 clinical medicine ,Recurrence ,Risk Factors ,Chronic Disease ,Schizophrenia ,medicine ,Humans ,Schizophrenic Psychology ,030212 general & internal medicine ,Psychiatry ,Psychology - Abstract
The idea of a triggering effect in schizophrenia emphasises the role of life events as precipitating factors which act on an individual's specific predisposition towards the illness (Wing, 1978).
- Published
- 1992
- Full Text
- View/download PDF
11. Oxygen Prescribing Is Improved by Nurse-Led Oxygen Policing in a Medical Admissions Unit (MAU)
- Author
-
John E Harvey, JO Bowen, and Andrew R L Medford
- Subjects
Nurse led ,medicine.medical_specialty ,chemistry ,business.industry ,Emergency medicine ,medicine ,chemistry.chemical_element ,business ,Oxygen ,Surgery ,Unit (housing) - Published
- 2009
- Full Text
- View/download PDF
12. Exploring reasons for variation in urinary catheterisation prevalence in care homes: a qualitative study
- Author
-
Jo Bowen, Elaine Freeman, Rebecca Howell-Jones, Mark Walker, and Cliodna A. M. McNulty
- Subjects
Aging ,medicine.medical_specialty ,Care homes ,business.industry ,Attitude of Health Personnel ,Health Services for the Aged ,Urinary catheterisation ,Communication ,Interprofessional Relations ,General Medicine ,Nursing Homes ,Interviews as Topic ,Variation (linguistics) ,Nursing ,Family medicine ,medicine ,Medical Staff ,Prevalence ,Humans ,Geriatrics and Gerontology ,business ,Urinary Catheterization ,Qualitative research ,Skilled Nursing Facilities - Published
- 2008
13. Variation in the use of H. pylori tests in UK general practice--a qualitative study
- Author
-
Jo Bowen, Elaine Freeman, Brendan Delaney, and Cliodna A. M. McNulty
- Subjects
Pediatrics ,medicine.medical_specialty ,Urea breath test ,Population ,Nice ,Endoscopy, Gastrointestinal ,Serology ,Helicobacter Infections ,medicine ,Humans ,Pharmacology (medical) ,Serologic Tests ,Medical prescription ,Practice Patterns, Physicians' ,education ,Referral and Consultation ,computer.programming_language ,education.field_of_study ,Hepatology ,biology ,medicine.diagnostic_test ,Helicobacter pylori ,Stool test ,business.industry ,Gastroenterology ,biology.organism_classification ,United Kingdom ,Test (assessment) ,Family medicine ,Clinical Competence ,business ,Family Practice ,computer - Abstract
Summary Background : Although serology is the main Helicobacter pylori test used by general practitioners in the UK, there is no information available on variation in requesting rates. Aim : To explore the reasons for any variation in H. pylori serology testing by general practices in the UK using qualitative methods. Methods : Serology requesting rates were determined using laboratory and population data. Staff from randomly selected practices in the lowest and highest quintiles of testing attended focus groups to discuss the management of H. pylori and dyspepsia. Transcribed data were analysed using an interpretative phenomenological approach. Results : Serology submission varied 600-fold (0.1–59/1000 population/year) and H. pylori positivity rate 17–100%. Low-testing practices were less aware of the benefits of H. pylori testing and had shorter endoscopy waiting times. They preferred endoscopy diagnosis over serology test. Three high-testing practices had a high non-white population with high H. pylori positivity. Most staff knew little about the predictive value of serology, the availability of urea breath test on prescription or the existence of a stool test. Conclusions : Seroprevalence of H. pylori is still high in dyspeptics, especially in non-white populations. Laboratories and primary care trusts should audit H. pylori requests and endoscopy referrals, target education at high endoscopy referrers and low H. pylori testers and inform clinicians of the more accurate H. pylori tests and NICE dyspepsia guidance.
- Published
- 2005
14. Chronic Fatigue Syndrome: a survey of GPs' attitudes and knowledge
- Author
-
Cliodna A. M. McNulty, Jo Bowen, Derek Pheby, and Andre Charlett
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Health Knowledge, Attitudes, Practice ,Fatigue Syndrome, Chronic ,business.industry ,Data Collection ,education ,virus diseases ,Physicians, Family ,Signs and symptoms ,Baseline data ,medicine.disease ,United Kingdom ,Postal questionnaire ,Key factors ,Chronic fatigue syndrome ,Global Positioning System ,Medicine ,Humans ,Positive attitude ,Family Practice ,business ,Psychiatry ,human activities - Abstract
Background. GPs need evidence and guidance to help them diagnose and manage Chronic Fatigue Syndrome (CFS)/ME appropriately. Objectives. The aim of this survey was to obtain baseline data and identify the factors associated with GPs' attitudes to and knowledge of CFS/ME. The attitude of GPs to the condition is an important indicator of likely prognosis. Methods. A postal questionnaire was sent to 1054 GPs served by Taunton, Bristol and Gloucester laboratories. GPs' attitudes to nine statements about CFS/ME were assessed and the factors associated with positive or negative responses were determined. Knowledge of the clinical features was also assessed. Results. 811 GPs (77%) returned the questionnaire. 48% of GPs did not feel confident with making a diagnosis of CFS/ME and 41% did not feel confident in treatment. 72% of GPs accepted CFS/ME as a recognisable clinical entity and those GPs had significantly more positive attitudes. Three other key factors that were significantly, positively associated with GPs' attitudes were knowing someone socially with CFS/ME, being male and seeing more patients with the condition in the last year. Conclusion. Despite the publication of guidance for GPs on CFS/ME, confidence with making a diagnosis and management was found to be low. Educational initiatives and guidance for GPs should stress the importance of accepting CFS/ME as a recognisable clinical entity, as this is linked to having a positive attitude and could lead to improved confidence to make a diagnosis and treat CFS/ME patients.
- Published
- 2005
15. Urinary catheterization in care homes for older people: self-reported questionnaire audit of catheter management by care home staff
- Author
-
I. Donald, C. Foy, K. Gunn, Jo Bowen, E. Freeman, Gillian Smith, T. Ejidokun, D. S. Tompkins, and Cliodna A. M. McNulty
- Subjects
Microbiology (medical) ,media_common.quotation_subject ,medicine.medical_treatment ,MEDLINE ,Gerontological nursing ,Nice ,Audit ,Urinary catheterization ,Nursing ,Geriatric Nursing ,Excellence ,Surveys and Questionnaires ,medicine ,Homes for the Aged ,Humans ,Primary nursing ,media_common ,computer.programming_language ,Aged ,Quality of Health Care ,Medical Audit ,business.industry ,General Medicine ,medicine.disease ,Nursing Homes ,Catheter ,Infectious Diseases ,Nursing Staff ,Medical emergency ,Guideline Adherence ,business ,Urinary Catheterization ,computer - Abstract
A self-administered questionnaire was used to determine care home staff's reported knowledge of the urinary catheter care standards published by the National Institute for Clinical Excellence (NICE) and the Association of Continence Care, and to see whether this differed in homes with higher catheterization rates. Seven hundred and fifty out of 1438 (52%) nursing and care staff from 37 randomly selected care homes with high, medium and low catheterization rates responded. There was no difference in reported practice in care homes in the three health districts sampled or those with differing catheterization rates. Eighty-three percent of the nursing staff and 40% of the other care staff received formal catheter care training. However, at least 10% of all staff reported not washing their hands before handling a catheter, and delaying emptying a urine bag until it was full, rather than three-quarters full. Only 45% of nursing staff and 40% of other care staff encouraged residents to empty their own catheter bags. Routine use of catheter maintenance solutions or bladder washouts was reported by 50% of all staff. Nursing staff (29%) and other care staff (54%) took urine specimens from the catheter bag tap. Compliance with standards has improved greatly since an audit in 1998. However, some non-compliance remains. There is a need for ongoing local audit and formal training in urinary catheter care, particularly for non-qualified care staff. Education is needed to ensure local implementation of NICE guidance.
- Published
- 2004
16. Barriers to opportunistic chlamydia testing in primary care
- Author
-
Cliodna A M, McNulty, Elaine, Freeman, Jo, Bowen, Julia, Shefras, and Kevin A, Fenton
- Subjects
Urban Health ,Editorials ,food and beverages ,Rural Health ,Chlamydia Infections ,Patient Acceptance of Health Care ,urologic and male genital diseases ,Original Papers ,female genital diseases and pregnancy complications ,England ,parasitic diseases ,Humans ,Mass Screening ,Family Practice ,Attitude to Health - Abstract
Opportunistic testing and screening for genital chlamydia infection in sexually active women under the age of 25 years can lead to a reduction in chlamydia infection and its related morbidity.To explore the barriers to testing for genital chlamydial infection in primary care.Qualitative study with focus groups.Rural and urban general practice in Southwest England.Focus groups were held with randomly selected high- and lowtesting general practices in Herefordshire, Gloucestershire and Avon. The high- and low-testing practices did not differ in their age/sex make-up, or by deprivation indices. Open questions were asked about the management of genitourinary symptoms and opportunistic testing for chlamydia. Data were collected and analysed concurrently until saturation occurred.Although staff from high test rate practices were much more aware of the evidence for opportunistic chlamydia testing and screening, none of the practices were happy to discuss chlamydia in a consultation unrelated to sexual health. The greatest barriers to opportunistic chlamydia testing and screening were lack of knowledge of the benefits of testing, when and how to take specimens, lack of time, worries about discussing sexual health, and lack of guidance. Healthcare staff stated that any increased testing should be accompanied by clear, concise primary care trust guidance on when and how to test, including how to obtain informed consent and perform contact tracing. Staff felt that testing could be undertaken at family planning clinics or with cervical smears if patients received information before the consultation. Alternatively, in larger practices specific chlamydia clinics could be held.The Department of Health needs to be aware of the extreme pressures that primary care staff are under, and the potential barriers to any screening implementation. Efforts to increase chlamydia screening in this setting should be accompanied by clear guidance and education. Any chlamydia clinics or increased testing must have appropriate financial and staff resources. Genitourinary medicine (GUM) clinics, or level three practices with GUM expertise, will need to be increased in parallel with testing in primary care to provide appropriate contact tracing and follow-up.
- Published
- 2004
17. Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy
- Author
-
Richard Stratton, Bahja Ahmed Abdi, M. Sydenham, Joanne S Haviland, Susan C Short, Jo Bowen, C. Westbury, John Yarnold, Lone Gothard, and Sue Davies
- Subjects
Adult ,medicine.medical_specialty ,Pathology ,medicine.medical_treatment ,Breast Neoplasms ,Mastectomy, Segmental ,Gastroenterology ,Breast cancer ,Fibrosis ,Breast Fibrosis ,Internal medicine ,medicine ,Biomarkers, Tumor ,Humans ,Radiology, Nuclear Medicine and imaging ,Prospective Studies ,Prospective cohort study ,Aged ,Neoplasm Staging ,Aged, 80 and over ,business.industry ,Interleukin-6 ,Research ,Connective Tissue Growth Factor ,Cancer ,Radiotherapy Dosage ,Biomarker ,Middle Aged ,medicine.disease ,Prognosis ,Combined Modality Therapy ,Radiation therapy ,CTGF ,Radiation Pneumonitis ,Oncology ,Radiology Nuclear Medicine and imaging ,Case-Control Studies ,Biomarker (medicine) ,Female ,Radiation fibrosis ,business ,Follow-Up Studies - Abstract
Background: radiation fibrosis is not easily measurable although clinical scores have been developed for this purpose. Biomarkers present an alternative more objective approach to quantification, and estimation in blood provides accessible samples. We investigated if blood cytokines could be used to measure established fibrosis in patients who have undergone radiotherapy for breast cancer.Methods: we studied two cohorts treated by breast-conserving surgery and radiotherapy in the UK START Trial A, one with breast fibrosis (cases) and one with no or minimal fibrosis (controls). Two candidate cytokines, plasma connective tissue growth factor (CTGF) and serum interleukin-6 (IL6) were estimated by ELISA. Comparisons between cases and controls used the t-test or Mann–Whitney test and associations between blood concentration and clinical factors were assessed using the Spearman rank correlation coefficient.Results: seventy patients were included (26 cases, 44 controls). Mean time since radiotherapy was 9.9 years (range 8.3-12.0). No statistically significant differences between cases and controls in serum IL6 (median (IQR) 0.84 pg/ml (0.57-1.14), 0.75 pg/ml (0.41-1.43) respectively) or plasma CTGF (331.4 pg/ml (234.8-602.9), 334.5 pg/ml (270.0-452.8) were identified. There were no significant associations between blood cytokine concentration and age, fibrosis severity, breast size or time since radiotherapy.Conclusions: no significant difference in IL6 or CTGF concentrations was detected between patients with breast fibrosis and controls with minimal or no fibrosis
- Published
- 2014
18. A one year prospective study of the effect of life events and medication in the aetiology of schizophrenic relapse
- Author
-
Philip Cramer, Javad Emami, Steven R. Hirsch, Anthony G. Jolley, Camilla Haw, Jo Bowen, and Mark Dickinson
- Subjects
Adult ,Male ,medicine.medical_specialty ,Placebo ,law.invention ,Life Change Events ,Placebos ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,Double-Blind Method ,law ,Recurrence ,Risk Factors ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Prospective Studies ,Risk factor ,Psychiatry ,Prospective cohort study ,Survival analysis ,Proportional Hazards Models ,Proportional hazards model ,Middle Aged ,medicine.disease ,Survival Analysis ,030227 psychiatry ,Clinical trial ,Psychiatry and Mental health ,Schizophrenia ,Chronic Disease ,Female ,Psychology ,Antipsychotic Agents ,Follow-Up Studies - Abstract
BackgroundWe set out to determine whether and to what degree life events independent of illness increase the risk of relapse in schizophrenia following withdrawal from medication in the previous 6 months, either by triggering a relapse in the following 4 weeks or by acting cumulatively over time.MethodSeventy-one patients fulfilling DSM–III–R criteria for schizophrenia with chronic illness were followed for 48 weeks and assessed on the LEDS scale. Half were treated with regular neuroleptic medication and half had been recently withdrawn from medication. A subgroup was randomised double-blind to treatment or placebo.ResultsA proportional hazards regression model showed that life events made a significant cumulative contribution over time (P< 0.05) to the risks of relapse and that ceasing medication made an independent contribution. The risk of relapse increased in proportion to the number of life events but no interaction between medication status and events could be detected, i.e. life events were not more closely associated with relapse on medication than off medication. For those of the sample exposed to the mean rate of life events during the study period, it was estimated that 23% of the relapse risk could be attributed to life events, and for those with twice the mean rate of events, 41%. In contrast, patients who continued on regular medication had 80% less risk of relapse than those who had been withdrawn from medication either by choice or under double-blind controlled conditions.ConclusionA contribution of life events to the risk of relapse in schizophrenia was confirmed by this study but the hypothesis that life events trigger relapse was not supported, nor was the hypothesis that life events are more relevant to relapse in patients on maintenance medication than in patients off medication.
- Published
- 1996
19. National Methadone Conference 1992 The 1990's: Comprehensive Treatment Orlando, Florida
- Author
-
Jo Bowen
- Subjects
Gerontology ,Psychiatry and Mental health ,medicine.medical_specialty ,business.industry ,Family medicine ,medicine ,Alternative medicine ,General Medicine ,business ,Methadone ,medicine.drug - Published
- 1993
- Full Text
- View/download PDF
20. Danger of assault at tribunal hearings
- Author
-
Jo Bowen
- Subjects
Psychiatry and Mental health ,Tribunal ,Political science ,Law - Published
- 1995
- Full Text
- View/download PDF
21. PATIENT WHO CHANGED MY PRACTICE
- Author
-
Jo Bowen
- Subjects
Surgical team ,Acute abdomen ,business.industry ,General Engineering ,medicine ,General Earth and Planetary Sciences ,General Medicine ,Medical emergency ,Surgical emergency ,medicine.symptom ,business ,medicine.disease ,General Environmental Science - Abstract
Towards the end of my house jobs my consultants puzzled about my decision to start training in psychiatry when I had declared my intention of becoming a general practitioner. Eight years on I want to share what it was about a patient who left abruptly and apparently unhealed which moved me to psychiatry. The young man came alone to the casualty department with symptoms and signs of an acute abdomen. A history of recent operations abroad for similar episodes led the surgical team to think about the possible reasons for a surgical emergency. With …
- Published
- 1995
- Full Text
- View/download PDF
22. Chronic Fatigue Syndrome: a survey of GPs' attitudes and knowledge.
- Author
-
Jo Bowen, Derek Pheby, Andre Charlett, and Cliodna McNulty
- Abstract
Background. GPs need evidence and guidance to help them diagnose and manage Chronic Fatigue Syndrome (CFS)/ME appropriately.Objectives. The aim of this survey was to obtain baseline data and identify the factors associated with GPs' attitudes to and knowledge of CFS/ME. The attitude of GPs to the condition is an important indicator of likely prognosis.Methods. A postal questionnaire was sent to 1054 GPs served by Taunton, Bristol and Gloucester laboratories. GPs' attitudes to nine statements about CFS/ME were assessed and the factors associated with positive or negative responses were determined. Knowledge of the clinical features was also assessed.Results. 811 GPs (77%) returned the questionnaire. 48% of GPs did not feel confident with making a diagnosis of CFS/ME and 41% did not feel confident in treatment. 72% of GPs accepted CFS/ME as a recognisable clinical entity and those GPs had significantly more positive attitudes. Three other key factors that were significantly, positively associated with GPs' attitudes were knowing someone socially with CFS/ME, being male and seeing more patients with the condition in the last year.Conclusion. Despite the publication of guidance for GPs on CFS/ME, confidence with making a diagnosis and management was found to be low. Educational initiatives and guidance for GPs should stress the importance of accepting CFS/ME as a recognisable clinical entity, as this is linked to having a positive attitude and could lead to improved confidence to make a diagnosis and treat CFS/ME patients. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
23. Trainees and research
- Author
-
Jo Bowen and Stuart Cox
- Subjects
Psychiatry and Mental health ,Psychology - Published
- 1993
- Full Text
- View/download PDF
24. Sigrid Herold, formerly Senior Registrar, Charing Cross Higher Training Scheme in Psychiatry, London
- Author
-
Jo Bowen
- Subjects
Scheme (programming language) ,Psychiatry and Mental health ,Medical education ,Senior registrar ,Psychology ,computer ,computer.programming_language - Published
- 1993
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.